Sowell Financial Services LLC Atara Biotherapeutics, Inc. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$12.89 - $16.58 $14,101 - $18,138	-1,094 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$14.0 - $20.72 $8,316 - $12,307	594 Added 118.8%	1,094 $14,000
Q4 2020 Jan 13, 2021	BUY	$12.67 - $26.23 $2,534 - $5,246	200 Added 66.67%	500 $10,000
Q3 2020 Nov 12, 2020	BUY	$11.92 - $15.87 $1,192 - $1,587	100 Added 50.0%	300 $4,000
Q2 2020 Aug 13, 2020	BUY	$7.53 - $14.93 $1,506 - $2,986	200 New	200 $3,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $710M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.